trazodone sold many brand antidepressant used treat major depressive disorder anxiety disorders difficulties medication taken common side effects include dry mouth feeling faint vomiting serious side effects may include suicide mania irregular heart rate pathologically prolonged unclear use pregnancy breastfeeding phenylpiperazine compound serotonin antagonist reuptake inhibitor sari trazodone also sedating trazodone approved medical use united states available generic commonly prescribed medication united states million primary use trazodone treatment unipolar major depression without data open doubleblind trials suggest antidepressant efficacy trazodone comparable amitriptyline doxepin mianserin furthermore trazodone shown anxiolytic properties low cardiotoxicity relatively mild side trazodone minimal anticholinergic activity especially welcomed treatment geriatric patients depression first became available three doubleblind studies reported trazodone antidepressant efficacy similar antidepressants geriatric patients unfortunately side effect trazodone orthostatic hypotension may cause dizziness increase risk falling devastating consequences elderly therefore side effect along sedation often makes trazodone less acceptable population compared newer compounds share lack anticholinergic activity rest side effect profile still trazodone often helpful geriatric patients depression severe agitation trazodone usually used dosage mgday treatment lower doses also used augment antidepressants initiating higher doses mgday used severe cases depression hospitalized patients trazodone usually administered multiple times per day oncedaily administration may similarly lowdose trazodone used offlabel treatment insomnia considered effective safe may also used treat antidepressantrelated trazodone secondmost prescribed agent insomnia early even though studies trazodone treatment sleep disturbances depressed systematic reviews metaanalyses published late including cochrane review found lowdose trazodone effective medication shortterm treatment insomnia depressed euthymic trazodone slightly improves subjective sleep quality smdtooltip standardized mean difference reduces number nighttime awakenings md smd average conversely appear affect sleep onset total sleep time time awake sleep onset sleep appears increase deep contrast certain quality evidence trazodone shortterm treatment insomnia rated low evidence available present inform longterm use trazodone treatment benefits trazodone insomnia must weighed potential adverse effects morning grogginess daytime sleepiness cognitive motor impairment postural hypotension among quality safety data use trazodone sleep aid currently trazodone used low doses range mgday higher doses mgday also american academy sleep medicines clinical practice guidelines recommended use trazodone treatment insomnia due inadequate evidence due harms potentially outweighing trazodone often used treatment anxiety disorders generalized anxiety disorder panic disorder well posttraumatic stress disorder ptsd disorder trazodone often used alternative benzodiazepines treatment anxiety however use trazodone anxiety disorders offlabel evidence effectiveness indications variable benefits ocd appear trazodone used treat sleep disturbances nightmares trazodone often used combination antidepressants selective serotonin reuptake inhibitors order augment antidepressant anxiolytic effects reduce side effects sexual dysfunction anxiety trazodone provided hydrochloride salt available form mg mg mg mg oral italy also available oral solution trittico mgml dosing pipette marked mg mg extendedrelease oral tablet formulation doses mg mg also lack anticholinergic side effects trazodone especially useful situations antimuscarinic effects particularly problematic eg patients benign prostatic hyperplasia closedangle glaucoma severe constipation trazodones propensity cause sedation dualedged sword many patients relief agitation anxiety insomnia rapid patients including individuals considerable psychomotor retardation feelings low energy therapeutic doses trazodone may tolerable sedation trazodone elicits orthostatic hypotension people probably consequence receptor blockade unmasking bipolar disorder may occur precautions trazodone include known hypersensitivity trazodone years combined antidepressant medications may increase possibility suicidal thoughts trazodone true member ssri class antidepressants still share many properties ssris especially possibility discontinuation syndrome medication stopped care must therefore taken coming medication usually gradual process tapering dose period time antidepressants may increase risk suicidal thoughts behaviors children young adults close monitoring emergence suicidal thoughts behaviors thus since trazodone may impair mental andor physical abilities required performance potentially hazardous tasks operating automobile machinery patient cautioned engage activities impaired compared reversible maoi antidepressant drug moclobemide impairment vigilance occurs trazodone found impair driving case reports noted cardiac arrhythmias emerging relation trazodone treatment patients preexisting mitral valve prolapse patients negative personal family histories cardiac qt prolongation reported trazodone therapy arrhythmia identified include isolated pvcs ventricular couplets two patients short episodes three four beats ventricular tachycardia several postmarketing reports made arrhythmia trazodonetreated patients preexisting cardiac disease patients preexisting cardiac disease results prospective studies available patients preexisting cardiac disease closely monitored particularly cardiac arrhythmias trazodone recommended use initial recovery phase myocardial infarction concomitant administration drugs prolong qt interval inhibitors may increase risk cardiac relatively rare side effect associated trazodone priapism likely due antagonism αadrenergic cases reported manufacturer estimated incidence abnormal erectile function one male patients treated trazodone risk side effect appears greatest first month treatment low dosages ie mgday early recognition abnormal erectile function important including prolonged inappropriate erections prompt discontinuation trazodone treatment spontaneous orgasms also reported trazodone clinical reports described trazodoneassociated psychosexual side effects women well including increased libido priapism clitoris spontaneous rare cases liver toxicity observed possibly due formation reactive elevated prolactin concentrations observed people taking appear increased around studies trazodone cognitive function mixed finding improvement others finding change finding trazodone seem worsen periodic limb movements trazodone associated increased risk falls older also associated increased risk hip fractures older sufficient data humans lacking use justified severity condition reported cases high doses trazodone precipitating serotonin also reports patients taking multiple ssris trazodone precipitating serotonin trazodone appears relatively safer tcas maois secondgeneration antidepressants overdose situations especially agent taken fatalities rare uneventful recoveries reported ingestion doses high mg one report cases overdose fatal nine patients also taken central nervous system cns depressants trazodone overdoses occur clinicians carefully monitor low blood pressure potentially serious toxic effect report fatal trazodone overdose torsades de pointes complete atrioventricular block developed along subsequent multiple organ failure trazodone plasma concentration mgl trazodone metabolized several liver enzymes including active metabolite metachlorophenylpiperazine mcpp known formed metabolized inhibition induction aforementioned enzymes various substances may alter metabolism trazodone andor mcpp leading increased andor decreased blood enzymes question known inhibited induced many medications herbs foods trazodone may interact substances potent inhibitors clarithromycin erythromycin fluvoxamine grapefruit juice ketoconazole ritonavir may lead increased concentrations trazodone decreased concentrations mcpp inducers like carbamazepine enzalutamide phenytoin phenobarbital st johns wort may result decreased trazodone concentrations increased mcpp inhibitors may result increased concentrations trazodone mcpp inducers may decrease examples potent inhibitors include bupropion cannabidiol duloxetine fluoxetine paroxetine quinidine ritonavir inducers include dexamethasone glutethimide haloperidol inhibitors may increase trazodone concentrations inducers may decrease trazodone concentrations examples potent inhibitors include ethinylestradiol found hormonal birth control fluoroquinolones eg ciprofloxacin fluvoxamine st johns wort potent inducers include phenytoin rifampin ritonavir tobacco study found ritonavir strong inhibitor moderate inducer increased trazodone peak levels increased areaunderthecurve levels decreased clearance trazodone associated adverse effects nausea hypotension another study found strong inducer carbamazepine reduced concentrations trazodone strong inhibitor thioridazine reported increase concentrations trazodone concentrations mcpp hand genotype found predict trazodone mcpp concentrations trazodone therapy although correlate side effects like dizziness prolonged corrected qt combination trazodone selective serotonin reuptake inhibitors ssris tricyclic antidepressants tcas monoamine oxidase inhibitors theoretical risk serotonin however trazodone studied combination ssris seemed safe hand cases excessive sedation serotonin syndrome reported combinations trazodone fluoxetine may due combined potentiation serotonin however may also related fact fluoxetine paroxetine strong inhibitors fluoxetine additionally weak moderate inhibitor accordingly fluoxetine reported result increased levels trazodone mcpp smokers lower levels trazodone higher ratios mcpp trazodone levels lower smokers mcpp trazodone ratio higher smokers whereas mcpp concentrations different smokers smoking known induce may involved trazodone mixed agonist antagonist various serotonin receptors antagonist adrenergic receptors weak histamine receptor antagonist weak serotonin reuptake specifically antagonist receptors partial agonist receptor antagonist also ligand receptor lower affinity however unknown whether trazodone acts full agonist partial agonist antagonist trazodone receptor partial agonist similarly buspirone tandospirone comparatively greater intrinsic range weak affinities ki reported trazodone human histamine receptor including trazodone minor active metabolite known metachlorophenylpiperazine mcpp metabolite may contribute degree pharmacological properties contrast trazodone mcpp agonist various serotonin relatively low affinity receptors unlike trazodone high affinity receptors weak affinity addition direct interactions serotonin receptors mcpp serotonin releasing agent similarly agents like fenfluramine contrast serotonin releasing agents however mcpp appear cause longterm serotonin depletion property thought related serotonergic trazodones receptor antagonism weak serotonin reuptake inhibition form basis common label antidepressant serotonin antagonist reuptake inhibitor sari studies estimated occupancy target sites trazodone based trazodone concentrations blood brain affinities trazodone human targets roughly half brain receptors blocked mg trazodone essentially receptors saturated mg trazodone clinically effective hypnotic doses trazodone mg occupancy serotonin transporter sert trazodone estimated mgday trazodone may almost completely occupy receptors doses significant occupancy number sites may also however another study estimated much lower occupancy sert receptors trazodone may act predominantly receptor antagonist mediate therapeutic benefits anxiety inhibitory effects serotonin reuptake receptors comparatively relation properties trazodone similar properties selective serotonin reuptake inhibitors particularly associated increased appetite weight gain unlike antagonists like moderate partial agonism may contribute trazodones antidepressant anxiolytic actions extent combined actions receptor antagonism serotonin reuptake inhibition occur moderate high doses doses trazodone lower effective antidepressant action frequently used effective treatment low doses exploit trazodones potent actions receptor antagonist properties antagonist receptors adequately exploit sert inhibition properties since insomnia one frequent residual symptoms depression treatment ssri hypnotic often necessary patients major depressive hypnotic potentially relieve insomnia treating insomnia patients major depression may also increase remission rates due improvement symptoms loss energy depressed thus ability low doses trazodone improve sleep depressed patients may important mechanism whereby trazodone augment efficacy trazodones potent blockade may cause side effects like orthostatic hypotension conversely along receptor antagonism may contribute efficacy hypnotic trazodone lacks affinity muscarinic acetylcholine receptors produce anticholinergic side effects mcpp nonselective serotonin receptor modulator serotonin releasing agent active metabolite trazodone suggested possibly play role therapeutic however research supported hypothesis mcpp might actually antagonize efficacy trazodone well produce additional side trazodone wellabsorbed oral bioavailability peak blood levels trazodone occur hours ingestion peak levels metabolite mcpp occur absorption somewhat delayed enhanced foodcitation needed trazodone sequestered medication volume distribution trazodone trazodone highly metabolic pathways involved metabolism case cytochrome enzymes may involved varying trazodone known extensively metabolized liver via hydroxylation noxidation several metabolites trazodone identified including dihydrodiol metabolite via hydroxylation metabolite hydroxylated para position metachlorophenyl ring via oxotriazolepyridinepropionic acid tpa mcpp via ndealkylation piperazinyl nitrogen mediated metabolite formed noxidation piperazinyl genotypes seem predict concentrations trazodone case large interindividual variations metabolism addition poor metabolizers dextromethorphan substrate eliminate mcpp slowly higher concentrations mcpp extensive mcpp formed trazodone metabolized via hydroxylation parahydroxylated may contribute pharmacological actions mcpp levels trazodone therapy trazodone nonetheless present concentrations known produce psychic physical effects humans mcpp administered case actions trazodone serotonin antagonism might partially overwhelm consequence production mcpp metabolite patients administered trazodone may test positive emit ii urine tests presence mdma elimination trazodone biphasic first phases halflife distribution hours following phases halflife elimination elimination halflife extendedrelease trazodone elimination halflife mcpp hours longer metabolites conjugated gluconic acid glutathione around trazodone found excreted urine within remaining drug metabolites excreted faeces via biliary elimination less drug excreted unchanged oral dose trazodone found excreted urine tpa conjugates dihydrodiol metabolite less unconjugated mcpp glucuronidated sulfated similarly trazodone trazodone triazolopyridine derivative phenylpiperazine structurally related nefazodone etoperidone derivatives trazodone developed italy angelini research laboratories secondgeneration developed according mental pain hypothesis postulated studying patients proposes major depression associated decreased pain sharp contrast antidepressants available time development trazodone showed minimal effects muscarinic cholinergic receptors trazodone patented marketed many countries world approved food drug administration fda first nontricyclic maoi antidepressant approved trazodone generic name drug inntooltip international nonproprietary name bantooltip british approved name dcftooltip dénomination commune française trazodone hydrochloride usantooltip united states adopted name usptooltip united states pharmacopeia banmtooltip british approved name jantooltip japanese accepted trazodone marketed large number brand names throughout major brand names include desyrel worldwide donaren brazil molipaxin ireland united kingdom oleptro united states trazorel canada trittico trazodone may effective treatment sexual dysfunction instance female sexual dysfunction erectile systematic review metaanalysis found indication trazodone may useful treatment erectile besides trazodone alone combination trazodone bupropion developmental code names tentative brand names lorexys orexa development treatment erectile dysfunction female sexual september phase clinical trials stage clinical development since least february trazodone may useful treatment certain symptoms like sleep disturbances alcohol withdrawal however reviews recommended use trazodone alcohol withdrawal due inadequate limited evidence suggests trazodone might useful treatment certain symptoms cocaine use trazodone reported effective treatment sleep cochrane reviews found trazodone effective treatment agitation another cochrane review found trazodone might useful treatment sleep disturbances systematic reviews found trazodone may effective behavioral psychological symptoms dementias frontotemporal dementia alzheimers trazodone studied adjunctive therapy treatment reported decrease negative symptoms without worsening positive symptoms although improvement negative symptoms trazodone also reported effective treating antipsychoticrelated extrapyramidal symptoms trazodone studied reported effective treatment limited evidence support might useful treatment night eating disorder trazodone might effective treatment adjustment may also effective treatment bruxism children trazodone may useful treatment certain chronic pain limited conflicting evidence support use trazodone treatment headaches migraines trazodone may useful treatment well diabetic may also useful treatment burning mouth narrative review claimed trazodone could used treatment complex regional pain trazodone may also effective treatment functional gastrointestinal may effective treatment noncardiac chest pain trazodone may useful promoting motor recovery trazodone used reduce anxiety stress improve sleep produce sedation dogs cats veterinary httpsenwikipediaorgwikitrazodone